- Sections
- A - Nécessités courantes de la vie
- A61K - Préparations à usage médical, dentaire ou pour la toilette
- A61K 31/277 - NitrilesIsonitriles ayant un cycle, p. ex. vérapamil
Détention brevets de la classe A61K 31/277
Brevets de cette classe: 1524
Historique des publications depuis 10 ans
|
130
|
145
|
123
|
114
|
147
|
117
|
111
|
112
|
104
|
36
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| The Regents of the University of California | 20534 |
35 |
| University of Tennessee Research Foundation | 757 |
26 |
| Vanda Pharmaceuticals, Inc. | 382 |
19 |
| Milestone Pharmaceuticals Inc. | 24 |
17 |
| Pitney Pharmaceuticals Pty Limited | 19 |
17 |
| Arvinas Operations, Inc. | 255 |
16 |
| The Trustees of Columbia University in the City of New York | 3618 |
15 |
| NeuroDerm, Ltd. | 143 |
15 |
| Bristol-myers Squibb Company | 4812 |
13 |
| Nikang Therapeutics, Inc. | 107 |
13 |
| Massachusetts Eye and Ear Infirmary | 389 |
12 |
| Ono Pharmaceutical Co., Ltd. | 419 |
12 |
| Orion Corporation | 748 |
12 |
| The George Institute for Global Health | 30 |
10 |
| National Institute of Biological Sciences, Beijing | 100 |
10 |
| Bayer Pharma AG | 1029 |
9 |
| Duke University | 3161 |
9 |
| Intrance Medical Systems Inc. | 14 |
9 |
| The Regents of the University of Michigan | 4903 |
8 |
| The General Hospital Corporation | 4809 |
8 |
| Autres propriétaires | 1239 |